The use of cytokines in the treatment of cornea inflammatory and dystrophic diseases (review)
https://doi.org/10.15372/SSMJ20200401
Abstract
Cytokines are unique biologically active substances that form the system of regulation of basic body functions that simultaneously with the nervous and endocrine systems maintain homeostasis under adverse conditions – the introduction of pathogens or violation of the integrity of tissues. Cytokines regulate the amplitude and duration of inflammatory and immune responses, so they are produced and secreted transiently and have a short half-life. These biologically active substances act in very low concentrations. At the same time, the main properties of cytokines are pleiotropy, lack of antigenic specificity, and the ability to form a cascade chain, that allows versatile correction of the spectrum of reparative processes. There are evidences of the possibility of using cytokines in the regeneration of damaged tissues in recent decades. In this connection, a new vector of search for pathogenetically directed ways to improve and restore lost functions using both individual representatives of cytokines and their natural complex is determined. The article reflects the basic information about the influence of cytokines on the development of various diseases of the cornea, as well as the methods of cytokine therapy in the treatment of these pathologies and prospects for their development.
Supporting agencies: Our research was supported by Foundation for Assistance to Small Innovative Enterprises «UMNIK 2018».
About the Authors
M. S. Denisko
Siberian Medical State University of Minzdrav of Russia
Russian Federation
Maryana S. Denisko
Russian Federation
Maryana S. Denisko
O. I. Krivosheina
Siberian Medical State University of Minzdrav of Russia
Russian Federation
Olga I. Krivosheina, doctor of medical sciences, professor
Russian Federation
Olga I. Krivosheina, doctor of medical sciences, professor
References
1. Ketlinkii S.A., Simbirtsev А.S. Cytokines. Saint-Petersburg: Foliant; 2008. 552 p. [In Russian].
2. Koval’chuk L.V., Ignat’eva G.A., Gankovskaya L.V. Immunology workshop tutorial. Moskow: GEOTAR-Media, 2014. 176 p. [In Russian].
3. Sibiryak S.V., Chereshnev V.A., Simbirtsev A.S., Sibiryak D.S., Gavrilova T.V. Cytokine regulation of biotransformation of xenobiotics and endogenous compounds. Ekaterinburg: UrO RAN, 2006. 148 p. [In Russian].
4. Khaitov R.M. Immunology: Тextbook for universities. 2nd edition. Moskow: GEOTAR-Media, 2013. 528 p. [In Russian].
5. Simbirtsev A.S. Cytokines as a new system, regulating body defense reactions. Tsitokiny i vospalenie = Cytokines and Inflammation. 2002; 1 (1): 9–16. [In Russian].
6. Simbirtsev A.S. Immunopharmacological aspects of the cytokine system. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2019; 18 (1): 84–95. doi: 10.20538/1682-0363-2019-1-84–95 [In Russian].
7. Nosik N.N. Cytokines in viral infections. Voprosy virusologii = Problems of Viorology. 2000; 45 (1): 4–10. [In Russian].
8. Bikbov M.M., Shevchuk N.E. Cytokines in clinical ophthalmology. Ufa, 2008. 152 p. [In Russian].
9. Simbirtsev A.S. Cytokines in the pathogenesis and therapy of human diseases. St. Petersburg: Foliant Publ., 2018. 512 p. [In Russian].
10. Fessler M.B., Malcolm K.C., Duncan M.W., Worthen G.S. Agenomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p 38 mitogen activated protein kinase. J. Biol. Chem. 2002; 277 (35): 31291–31302. doi:10.1074/jbc.m200755200
11. Wang D., Zhang B., Shi H., Yang W., Bi M.C., Song X.F., Zhang C., Cheng J.H., Hao J.L., Song E. Effect of endothelial progenitor cells derived from human umbilical cord blood on oxygen-induced retinopathy in mice by intravitreal transplantation. Int. J. Ophthalmol. 2016; 9 (11): 1578–1583. doi: 10.18240/ijo.2016.11.07
12. Xi X., McMillan D.H., Lehmann G.M., Sime P.J., Libby R.T., Huxlin K.R., Feldon S.E., Phipps R.P. Ocular fibroblast diversity: Implications for inflammation and ocular wound healing. Invest. Ophthalmol. Vis. Sci. 2011; 52 (7): 4859–4865. doi:10.1167/iovs.10-7066
13. Slepova O.S. Pathogenetic role of cytokines in various eye diseases as a basis for the prediction and choice of tactics of immunocorrective treatment. Rosiiskiy oftal’mologicheskiy zhurnal = Russian Ophthalmological Journal. 2008; (3): 36–42. [In Russian].
14. Grinev A.G. Postoperative inflammation in cataract surgery with intraocular correction. Vestnik oftal’mologii = The Russian Annals of Ophthalmology. 2003; (2): 47–50. [In Russian].
15. Lam D.L., Axtelle J., Rath S., Dyer A., Harrison B., Rogers C., Menon N., van Gelder R.N. A rayleigh scatterbased ocular flare analysis meter for flare photometry of the anterior chamber. Translat. Vis. Sci. Technol. 2015; 4 (6): 7. doi: 10.1167/tvst.4.6.7
16. Galvis V., Sherwin T., Tello A., Merayo J., Barrera R., Acera A. Keratoconus: an inflammatory disorder? Eye. 2015; 29 (7): 843–859. doi: 10.1038/eye.2015.63
17. Wang L., Zhang Z., Koch D.D., Jia Y., Cao W., Zhang S. Anterior chamber interleukin 1beta, interleukin 6 and prostaglandin E2 in patients undergoing femtosecond laser-assisted cataract surgery. Brit. J. Ophthalmol. 2016; 100 (4): 579–582. doi: 10.1136/bjophthalmol-2015-307586
18. Sharma R.K., Rogojina A.T., Chalam K.V. Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor. Mol. Vis. 2009; 15: 60–69.
19. Tzovolou D.N., Lamari F., Mela E.K., Gartaganis S.P., Karamanos N.K. Capillary electrophoretic analysis of brimonidine in aqueous humor of the eye and blood sera and relation of its levels with intraocular pressure. Biomed. Chromatogr. 2000; 14 (5): 301–305. doi: 10.1002/1099-0801(200008) 14:5<301::AID-BMC4>
20. 0.CO;2-Q
21. Shaimova V.A. The role of proinflammatory cytokines in eye diseases. Tsitokiny i vospalenie = Cytokines and Inflammation. 2005; 4 (2): 13–15. [In Russian].
22. Biswas P.S., Banerjee K., Zheng M., Rouse B.T. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J. Leukoc. Biol. 2004; 76 (4): 868–875. doi: 10.1189/jlb.0504280
23. Biswas P.S. IL-17 in Renal Immunity and Autoimmunity. J. Immunol. 2018; 201 (11): 3153–3159. doi: 10.4049/jimmunol.1801042
24. Kasparov A.A. Local Express autocatakinetic (complex of cytokines) in thetreatment of viral and non-virallesions of the eye. Vestnik oftal’mologii = The Russian Annals of Ophthalmology. 2001; (3): 45–47. [In Russian].
25. Kasparova E.A., Fadeeva L.L., Pavlyuk A.S., Pereverzina O.K., Kasparov A.A. To the question about the theoretical justification of methods local express autocatakinetic. Vestnik oftal’mologii = The Russian Annals of Ophthalmology. 2002; (3): 25–27. [In Russian].
26. Elegecheva O.N., Krivosheina O.I., Zapuskalov I.V. Use of autologous blood mononuclear cells in the complex treatment of corneal ulcers. Vestnik oftal’mologii = The Russian Annals of Ophthalmology. 2008; (5): 32–35. [In Russian].
27. Elegecheva O.N., Krivosheina O.I., Zapuskalov I.V. The treatment of experimental ulcers of the cornea by autologous mononuclear cells. New technologies in ophthalmology. Materials of the international scientific and practical conference. Kazan, 2008. 116–119. [In Russian].
28. Levchenko N.A., Zapuskalov I.V., Krivosheina O.I. Dynamics of inflammatory and regenerative processes in experimental corneal ulcer on the background of autologous blood mononuclears. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2011; (1): 38–42. [In Russian].
29. Levchenko N.A., Krivosheina O.I. The effect of autologous blood mononuclear cells in regenerative processes in the stromal damage in the cornea in the experiment. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2011; (4): 27–31. doi: 10.20538/1682-0363-2011-4-27-31 [In Russian].
30. Levchenko N.A., Krivosheina O.I., Zapuskalov I.V. Evaluation of clinical efficacy of intrastromal administration of autologous blood mononuclears in the treatment of herpetic ulcerative keratitis. Actual problems of ophthalmology: сollection of scientific works of VI all-Russian scientific conference of young scientists. Moscow, 2011. 173–174. [In Russian].
31. Karthikeyan R.S., Vareechon C., Prajna N.V., Dharmalingam K., Pearlman E., Lalitha P. IL-17 expression in peripheral blood neutrophils from fungal keratitis patients and healthy cohorts in south India. J. Infect. Dis. 2015; 211 (1): 130–134. doi: 10.1093/infdis/jiu381
32. Taylor P.R., Roy S., Meszaros E.C., Sun Y., Howell S.J., Malemud C.J., Pearlman E. JAK/STAT regulation of Aspergillus fumigatus corneal infections and IL-6/23-stimulated neutrophil, IL-17, elastase, and MMP9 activity. J. Leukoc. Biol. 2016; 100 (1): 213–222. doi: 10.1189/jlb.4A1015-483R
33. Suryawanshi A., Veiga-Parga T., Reddy P.B., Rajasagi N.K., Rouse B.T. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J. Immunol. 2012; 188 (7): 3434–3446. doi: 10.4049/jimmunol.1102602
34. Liu R., Gao C., Chen H., Li Y., Jin Y., Qi H. Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease. PloS One. 2017; 12 (4): e0173301. doi: 10.1371/journal.pone.0173301
35. Suryawanshi A, Cao Z., Sampson J.F., Panjwani N. IL-17A– mediated protection against acanthamoeba keratitis. J. Immunol. 2015; 194 (2): 650–663. doi: 10.4049/jimmunol.1302707
36. Carnt N., Montanez V.M., Galatowicz G., Veli N., Calder V. Tear cytokine levels in contact lens wearers with acanthamoeba keratitis. Cornea. 2017; 36 (7): 791–798. doi: 10.1097/ICO.0000000000001238
37. Suryawanshi A., Cao Z., Sampson J.F., Panjwani N. IL-17A-mediated protection against Acanthamoeba keratitis. J Immunol. 2015; 194 (2): 650–663. doi: 10.4049/jimmunol.1302707
38. Qin X.H., Ma X., Fang S.F., Zhang Z.Z., Lu J.M. IL-17 produced by Th17 cells alleviates the severity of fungal keratitis by suppressing CX43 expression in corneal peripheral vascular endothelial cells. Cell Cycle. 2019; 18 (3): 274–287. doi: 10.1080/15384101.2018.1556059
Review
For citations:
Denisko M.S., Krivosheina O.I. The use of cytokines in the treatment of cornea inflammatory and dystrophic diseases (review). Сибирский научный медицинский журнал. 2020;40(4):4-10. (In Russ.) https://doi.org/10.15372/SSMJ20200401
Views:
402
Email this article 